BERGENBIO

Chemical preparations, chemical compounds, biochemical preparations and biologic compounds for scientific or industrial purposes, or for use in laboratories or in research; chemical preparations, chemical compounds, biochemical preparations and biologic compounds for analytical and diagnostic purposes in laboratory use; chemical preparations, chemical compounds, biochemical preparations and biologic compounds for the experimental production of drugs, pharmaceutical products and biotechnological preparations; chemical preparations, chemical compounds, biochemical preparations and biologic compounds for use in the development and manufacture of diagnostic products and services, drugs and pharmaceutical products, namely, the diagnosis and treatment of cancers, including lung cancer, leukaemia, aggressive cancers, immune evasive cancers and metastatic cancers; chemical preparations, chemical compounds, biochemical preparations and biologic compounds for use in the development and manufacture of drugs and pharmaceutical products, namely, drugs and pharmaceutical products that target axl, akt3 or other genes, proteins, kinases and enzymes; active chemical and biochemical ingredients and components for use in the development and manufacture of diagnostic products and services, drugs and pharmaceutical products, namely, for the diagnosis and treatment of cancers, including lung cancer, leukaemia, aggressive cancers, immune evasive cancers and metastatic cancers; antibodies, small molecules and proteins for scientific or industrial purposes, or for use in laboratories or in research; antibodies, small molecules and proteins for use in the development and manufacture of diagnostic products and services, drugs and pharmaceutical products, namely, for the diagnosis and treatment of cancers, including lung cancer, leukaemia, aggressive cancers, immune evasive cancers and metastatic cancers; antibodies, small molecules and proteins for use in the development and manufacture of drugs and pharmaceutical products, namely, drugs and pharmaceutical products that target axl, akt3 or other genes, proteins, kinases and enzymes; antibodies, anti-axl antibodies, small molecules, small molecules that inhibit axl kinase, selective inhibitors, selective axl inhibitors, selective axl kinase inhibitors and selective inhibitors of cell surface proteins for scientific or industrial purposes, or for use in laboratories or in research; antibodies, anti-axl antibodies, small molecules, small molecules that inhibit axl kinase, selective inhibitors, selective axl inhibitors, selective axl kinase inhibitors and selective inhibitors of cell surface proteins for use in the development and manufacture of diagnostic products and services, drugs and pharmaceutical products, namely, for the diagnosis and treatment of cancers, including lung cancer, leukaemia, aggressive cancers, immune evasive cancers and metastatic cancers; antibodies, anti-axl antibodies, small molecules, small molecules that inhibit axl kinase, selective inhibitors, selective axl inhibitors, selective axl kinase inhibitors and selective inhibitors of cell surface proteins for use in the development and manufacture of drugs and pharmaceutical products, namely, drugs and pharmaceutical products that target axl, akt3 or other genes, proteins, kinases and enzymes; proteins for use in kinase inhibiting technology, for scientific purposes

Drugs and pharmaceutical products for medical purposes, namely, medications for the treatment of cancer and severe respiratory infections; drugs and pharmaceutical products for medical purposes incorporating antibodies, anti-axl antibodies, small molecules, small molecules that inhibit axl kinase, selective inhibitors, selective axl inhibitors, selective axl kinase inhibitors, or selective inhibitors of cell surface proteins, namely, medications for the treatment of cancer and severe respiratory infections; drugs and pharmaceutical products for medical purposes, for use in oncology and for the treatment of cancers, lung cancer, leukaemia, aggressive cancers, immune evasive cancers and metastatic cancers; drugs and pharmaceutical products that target axl, akt3 or other genes, proteins, kinases and enzymes; chemical preparations, chemical compounds, biochemical preparations and biologic compounds for medical purposes; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for medical laboratory analysis; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease testing, namely, the testing for lung cancer, leukaemia, aggressive cancers, immune evasive cancers, metastatic cancers and severe respiratory infections; antibodies, small molecules and proteins for medical purposes; antibodies, anti-axl antibodies, small molecules, small molecules that inhibit axl kinase, selective inhibitors, selective axl inhibitors, selective axl kinase inhibitors and selective inhibitors of cell surface proteins for medical purposes; protein synthesis inhibitors for medical purposes

Drug discovery and pharmaceutical drug development services; scientific research services; research and development services in the fields of oncology and immunology; scientific research services related to the role of axl and related kinase signalling in disease; scientific research services related to axl biology and its role in mediating aggressive disease; scientific research services related to biomarker discovery; scientific research services related to the development of diagnostic products and services, in the field of treatment of cancers, including lung cancer, leukaemia, aggressive cancers, immune evasive cancers and metastatic cancers; scientific research services related to improving the efficacy of chemotherapy, targeted cancer therapy and immunooncology drugs; research and development services in the field of antibodies, small molecules and proteins; conducting and providing research and development services for others in the field of antibody and small molecule technology; medical and biotechnology research services; research, development and engineering of antibodies, small molecules and proteins, namely, anti-axl antibodies, small molecules that inhibit axl kinase, selective inhibitors, selective axl inhibitors, selective axl kinase inhibitors and selective inhibitors of cell surface proteins; laboratory research services relating to the production of antibodies, small molecules and proteins, namely, anti-axl antibodies, small molecules that inhibit axl kinase, selective inhibitors, selective axl inhibitors, selective axl kinase inhibitors and selective inhibitors of cell surface proteins; researching and developing the use of antibodies, small molecules and proteins for the treatment of patients; information, consultancy and advisory services related to the aforesaid services